Plerixafor approved for autologous hematopoietic stem-cell transplantation.
Traynor
Kate
K
D001596:Benzylamines; D000080027:Cyclams; D017277:Drug Approval; D004359:Drug Therapy, Combination; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000639:trends*; D006571:Heterocyclic Compounds / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors; D014481:United States
D001596:Benzylamines; C527276:CXCR4 protein, human; D000080027:Cyclams; D006571:Heterocyclic Compounds; D019718:Receptors, CXCR4; D016179:Granulocyte Colony-Stimulating Factor; C088327:plerixafor